Refreshing results…
Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML
UploadIn vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis
UploadUnified classification and risk-stratification in Acute Myeloid Leukemia
Download from www.nature.comCystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia
UploadUnbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma
UploadTargeting Chromatin Regulation in Acute Myeloid Leukemia
Download from doi.orgKAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements
UploadDissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML
Download from www.nature.comLoss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells
Download from doi.orgGenetic modification of primary human B cells to model high-grade lymphoma
Download from www.nature.comKinase Networks Regulate Metabolism: I'D(H1) Never Have Guessed!
UploadContrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML
Download from rupress.orgMissing publications? Search for publications with a matching author name.